Corleen Roche
Finanzdirektor/CFO bei CG ONCOLOGY, INC.
Vermögen: 72 400 $ am 30.04.2024
Profil
Corleen M.
Roche is currently the Chief Financial Officer, CAO & Secretary at CG Oncology, Inc. She previously held positions as the Chief Financial Officer-US at Biogen, Inc., the Chief Financial Officer at Sandoz, Inc., the Chief Financial & Accounting Officer at Immunome, Inc., the Chief Financial Officer at Iogenetics LLC, and the Chief Financial Officer at Wyeth Pharmaceuticals, Inc. Ms. Roche obtained her undergraduate degree from Villanova University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CG ONCOLOGY, INC.
0,00% | 29.01.2024 | 2 000 ( 0,00% ) | 72 400 $ | 30.04.2024 |
IMMUNOME, INC.
-.--% | 08.06.2023 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Corleen Roche
| Unternehmen | Position | Beginn |
|---|---|---|
| CG ONCOLOGY, INC. | Finanzdirektor/CFO | 01.01.2024 |
Ehemalige bekannte Positionen von Corleen Roche
| Unternehmen | Position | Ende |
|---|---|---|
| IMMUNOME, INC. | Finanzdirektor/CFO | 02.01.2024 |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Finanzdirektor/CFO | - |
| Iogenetics LLC | Finanzdirektor/CFO | - |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Finanzdirektor/CFO | - |
| BIOGEN INC. | Finanzdirektor/CFO | - |
Ausbildung von Corleen Roche
| Villanova University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| IMMUNOME, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| CG ONCOLOGY, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Health Technology |
| Iogenetics LLC | |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Health Technology |
